The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human, first-in-class phase I study of MTL-CEBPA, a small activating RNA (saRNA) targeting the transcription factor C/EBP-α in patients with advanced liver cancer.
 
Debashis Sarker
Honoraria - Pfizer; Pfizer (I)
Consulting or Advisory Role - Baxalta; Blueprint Medicines; Eisai (I); Ipsen (I); Novartis
Travel, Accommodations, Expenses - Bayer; ipsen
 
Elizabeth R. Plummer
Honoraria - BMS Brazil; Roche
Consulting or Advisory Role - Astex Pharmaceuticals; Bayer; Clovis Oncology; Crystal Pharma; Genmab; Novartis; Pierre Fabre; Vertex
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - MSD Oncology
 
Bristi Basu
Consulting or Advisory Role - Astex Pharmaceuticals (Inst); Baxter; Celgene (Inst)
Research Funding - Celgene
Travel, Accommodations, Expenses - Bayer; Bayer Health
 
Tim Meyer
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Research Funding - Bayer (Inst); BTG (Inst); Ipsen (Inst)
 
Kai-Wen Huang
Stock and Other Ownership Interests - MINA THERAPEUTICS
 
T.R. Jeffry Evans
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Baxter (Inst); Bristol-Myers Squibb (Inst); Caris Life Sciences (Inst); Celgene (Inst); Eisai (Inst)
Speakers' Bureau - Bristol-Myers Squibb; Celgene
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly (Inst); Roche (Inst); Verastem (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Duncan Spalding
No Relationships to Disclose
 
Yuk Ting Ma
Honoraria - Baxalta; Bayer
Consulting or Advisory Role - Baxalta
Research Funding - Astellas Oncology (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Targovax (Inst)
Travel, Accommodations, Expenses - Bayer
 
Daniel H. Palmer
Honoraria - Bayer; Bristol-Myers Squibb; Celgene; Nucana
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Nucana
Research Funding - Bayer; Nucana
 
Cheng Ean Chee
No Relationships to Disclose
 
Han Chong Toh
No Relationships to Disclose
 
Nagy A Habib
Stock and Other Ownership Interests - MINA THERAPEUTICS
Research Funding - MINA THERAPEUTICS
Travel, Accommodations, Expenses - MINA THERAPEUTICS